US2003027758A1PendingUtilityA1

Methods of treating intestinal ischemia using heparin-binding epidermal growth factor

56
Assignee: CHILDRENS HOSPITAL INCPriority: Oct 31, 1997Filed: Mar 12, 2002Published: Feb 6, 2003
Est. expiryOct 31, 2017(expired)· nominal 20-yr term from priority
Inventors:Gail E. BesnerSrikumar B. Pillai
A61K 38/1808
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides methods of treating pathologic conditions associated with intestinal ischemia. In the methods, patients at risk for or suffering from intestinal ischemia are treated with a heparin-binding epidermal growth factor product.

Claims

exact text as granted — not AI-modified
We claim:  
     
         1 . A method of treating pathological conditions associated with intestinal ischemia comprising administering an HB-EGF product to patients in an amount effective to reduce intestinal cell necrosis.

Join the waitlist — get patent alerts

Track US2003027758A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.